Krebs Von den Lungen-6 as a predictive indicator for the risk of secondary pulmonary fibrosis and its reversibility in COVID-19 patients

Mingshan Xue(Guangzhou Medical University), Baoqing Sun(First Affiliated Hospital of Guangzhou Medical University), Yingjie Zhen(First Affiliated Hospital of Guangzhou Medical University), Runpei Lin(First Affiliated Hospital of Guangzhou Medical University), Zhifeng Huang(First Affiliated Hospital of Guangzhou Medical University), Hao Chen(Tongji Hospital), Ning Li(University of Macau), Teng Zhang(University of Macau), Hui Wang(East China Normal University), Yifeng Zeng(First Affiliated Hospital of Guangzhou Medical University), Haisheng Hu(Guangzhou Experimental Station), Luqian Zhou(First Affiliated Hospital of Guangzhou Medical University), Xiaohua Douglas Zhang(University of Macau)
International Journal of Biological Sciences
January 1, 2021
10.7150/ijbs.58825
Cited by 34

Related Papers

Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients
|Emerging Microbes & Infections|2020|535
Effect of Remote Ischemic Conditioning vs Usual Care on Neurologic Function in Patients With Acute Moderate Ischemic Stroke
|JAMA|2022|178
Public Health Measures and the Control of COVID-19 in China
|Clinical Reviews in Allergy & Immunology|2021|134
Pathophysiological factors underlying heatstroke
|Medical Hypotheses|2006|124
Bifidobacterium lactis Probio-M8 Adjuvant Treatment Confers Added Benefits to Patients with Coronary Artery Disease via Target Modulation of the Gut-Heart/-Brain Axes
|mSystems|2022|93